James Christensen, Ph.D., and Nancy Whiting, Pharm.D., join Board of DirectorsGeorge Demetri, M.D., to serve as first member of Clinical Advisory BoardSAN DIEGO (BUSINESS WIRE) Boundless Bio, a clinical stage, next-generation precision oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver.
/PRNewswire/ The "Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis".